Panacea Life Sciences Holdings, Inc. (PLSH): Total Liabilities
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$26.27M
As of 2023-12-31
+2.1%
3-year compound annual growth
+50.2%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $26.27M | +21.5% | 2024-04-01, Balance as of period end |
| 2022-12-31 | $21.63M | +29.7% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $16.68M | -32.3% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $24.65M | n/a | 2022-03-31, Balance as of period end |
| 2020-03-31 | $4.95M | n/a | 2021-04-23, Balance as of period end |
| 2019-12-31 | $4.13M | n/a | 2021-04-23, Balance as of period end |
| 2019-09-30 | $2.11M | n/a | 2021-04-23, Balance as of period end |
| 2018-12-31 | $3.44M | +44.0% | 2020-05-22, Balance as of period end |
| 2017-12-31 | $2.39M | +282.1% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $625.0K | +250.7% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $178.2K | +356.4% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $39.0K | n/a | 2016-02-29, Balance as of period end |